Orthopediatrics  logo
KIDSOrthopediatrics
Trade KIDS now
Orthopediatrics  primary media

About Orthopediatrics

Orthopediatrics (NASDAQ:KIDS) specializes in developing orthopedic products and solutions exclusively designed for children. This unique focus addresses the distinct challenges in pediatric orthopedics and promotes better surgical outcomes for younger patients. Their diverse product portfolio includes innovative medical devices for trauma and deformities, scoliosis, and sports medicine, engineered to meet the growing needs of pediatric orthopedic surgery. With a strong commitment to improving the lives of children around the world, Orthopediatrics aims to expand its reach and enhance its product offerings through ongoing research and strategic partnerships. The company's primary objective is to be at the forefront of pediatric orthopedic care, ensuring surgeons have the specialized tools needed to care for young patients effectively.

What is KIDS known for?

Snapshot

Public US
Ownership
2006
Year founded
362
Employees
Warsaw, United States
Head office
1 of 4
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Produtos e/ou serviços de Orthopediatrics

  • Pediatric orthopedic implants for trauma and deformity corrections, specializing in technology tailored for growing bodies.
  • Surgical navigation systems designed to enhance precision in pediatric orthopedic surgeries.
  • Custom implants and instruments for rare and complex pediatric orthopedic conditions, providing personalized solutions.
  • A comprehensive line of spinal hardware designed specifically for pediatric patients, including solutions for scoliosis.
  • Clubfoot solutions including braces and bar systems, supporting non-invasive treatments in infants and young children.
  • Educational programs and resources for healthcare professionals on the latest advancements in pediatric orthopedic care.

equipe executiva do Orthopediatrics

  • Mr. Mark C. ThrodahlExecutive Chairman
  • Mr. David R. BaileyPresident, CEO & Director
  • Mr. Fred L. HiteCFO, Principal Financial & Accounting Officer, COO and Director
  • Mr. Daniel J. Gerritzen J.D.Executive VP of Legal, General Counsel & Secretary
  • Mr. Gregory A. OdlePresident of Scoliosis
  • Mr. Joseph W. HauserPresident of Trauma, Deformity Correction & OPSB
  • Mr. Kevin L. Unger CHE, MBA/MSHAPresident of Enabling Technologies
  • Mr. Mark KarshnerSenior Vice President of International Sales
  • Ray GarrisonSenior Vice President of Quality & Regulatory and Clinical

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.